Submitted by Anonymous (not verified) on 3 February 2025 - 15:14
Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation: 26/07/2018, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation: 26/07/2018, Revision: 13, Status: Authorised